United States Ex Rel. McGrath v. Microsemi Corp.
Cases that cite this one
10 later published cases cite this decision.
- United States ex rel. Deborah Sheldon v. Allergan Sales, LLC (4th Cir. 2022)
- United States ex rel. Deborah Sheldon v. Allergan Sales, LLC (4th Cir. 2022)
- Morsell v. Symantec Corporation (District Court, District of Columbia 2023)
- ELLSWORTH ASSOCIATES, LLP v. CVS HEALTH CORPORATION (District Court, E.D. Pennsylvania 2023)
- Michael Yarberry v. Supervalu Incorporated (7th Cir. 2021)
- Kuzma v. Northern Arizona Healthcare Corporation (United States District Court for the District of Arizona 2021)
- Kuzma v. Northern Arizona Healthcare Corporation (United States District Court for the District of Arizona 2020)
- Kuzma v. Northern Arizona Healthcare Corporation (United States District Court for the District of Arizona 2020)
- United States of America v. Supervalu Inc (District Court, C.D. Illinois 2020)
- The United States of America v. Safeway, Inc. (District Court, C.D. Illinois 2020)
This list shows which later cases cite this one. It does not say how they treated it, and no review of that has been done. Not a substitute for Shepard’s or KeyCite — verify before relying.
Opinion
MEMORANDUM **
Mark McGrath, on behalf of the United States of America, appeals the district court’s order dismissing his qui tam complaint under Rules 8(a) and 9(b) of the Federal Rules of Civil Procedure and denying leave to amend. We have jurisdiction under 28 U.S.C. § 1291.
McGrath’s complaint failed to state a false certification claim under the False Claims Act (FCA), 31 U.S.C. §§ 3729-3733, because the complaint failed to plead facts plausibly alleging that compliance with the International Traffic in Arms Regulations (ITAR) was material to the Government’s decision to pay White Electronic Designs Corporation and Microsemi Corporation (collectively, “Microsemi”). Universal Health Servs., Inc. v. United States ex rel. Escobar, — U.S. -, 136 S.Ct. 1989, 2002-03, 195 L.Ed.2d 348 (2016). Moreover, even assuming that the statement “ITAR controlled” on Microse-mi’s receipts constituted a false representation that Microsemi was in compliance with ITAR, the complaint cannot plead facts sufficient to support an inference that Microsemi knew it had failed to comply with ITAR at the time of the representation because Microsemi’s good faith interpretation of the term “disclose” in 22 C.F.R. § 120.17 at that time was reasonable. See Safeco Ins. Co. of Am. v. Burr, 551 U.S. 47, 70 n.20, 127 S.Ct. 2201, 167 L.Ed.2d 1045 (2007). Because McGrath cannot establish Microsemi’s scienter as a matter of law, and has not indicated what facts he could add to the complaint to establish that Microsemi’s alleged ITAR violation was material to the Government’s payment decision, the district court did not err in denying leave to amend. See id.; Hildes v. Arthur Andersen LLP, 734 F.3d 854, 859 (9th Cir. 2013).
Finally, McGrath waived his argument that Microsemi provided the Government worthless products by failing to raise it in his opening brief. Martinez-Serrano v. I.N.S., 94 F.3d 1256, 1259 (9th Cir. 1996). To the extent McGrath is now raising the modified argument that Microsemi knowingly demanded payment for products that had lost value due to Microsemi’s failure to comply with ITAR, such a claim fails for the same reasons as his false certification claim. 1
AFFIRMED.
This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
. McGrath failed to raise his FCA claim for fraud in the inducement before the district court. We therefore decline to address this issue on appeal. Bolker v. Comm'r of Internal Revenue, 760 F.2d 1039, 1042 (9th Cir. 1985).
Case-law data current through December 31, 2025. Source: CourtListener bulk data.